MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

893 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
893 works in the cohort · of 4,299,418page 18 of 18

Labels cover 0 of 893 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 893 of 893 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Ruxolitinib (Opzelura)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ruxolitinib (Opzelura)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
POSTER: MPN-574 Characteristics and Clinical Outcomes in Patients With Polycythemia Vera Receiving Ruxolitinib After Hydroxyurea: A Longitudinal Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices Trial (REVEAL)
Aaron T. Gerds, Michael R. Grunwald, Stephen T. Oh, Evan Braunstein, Zhenyi Xue, Valkal Bhat +2 more
2023· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)
Vikas Gupta, Kwang Woo Ahn, Xiaochun Zhu, Zhen‐Huan Hu, Parameswaran Hari, Richard T. Maziarz +3 more
2012· article· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
POSTER: MPN-346 INDEPENDENCE: Enrolling Phase III Trial to Study the Efficacy and Safety of Luspatercept versus Placebo in Patients With Myelofibrosis on JAK2 Inhibitor (JAK2i) Therapy Requiring Red Blood Cell Transfusions (RBCTs)
Jean‐Jacques Kiladjian, Claire Harrison, Ruben A. Mesa, Haifa Kathrin Al‐Ali, John Mascarenhas, Fabián Sanabria +3 more
2023· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
ID: 116
Diana Saleiro, Barbara Kroczyńska, Swarna Mehrotra, Amit Verma, Eleanor N. Fish, Leonidas C. Platanias
2015· article· en· Cytokine· Medicine
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
affno abstractunlabeled
Corrigendum to GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis [J Thromb Haemost. 2021 Oct;19(10):2612-2617]
Karyn Mégy, Kate Downes, Marie‐Christine Morel‐Kopp, José María Bastida, Shannon Brooks, Loredana Bury +10 more
2023· erratum· en· Journal of Thrombosis and Haemostasis· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
venueno affno abstractunlabeled
10.1016/s0246-0521(21)44704-2
2000· article· en· Time to knit· Medicine
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations

How this was built: Screen · Findings · About